Halil Cumhur Yıldırım

10PUBLICATIONS
23CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 28, 2026
Is radiotherapy still an option for residual retroperitoneal masses in stage IIC seminoma?

|Apr 06, 2026
Whole brain radiotherapy and simultaneous integrated boost: is it still a viable treatment for multiple brain metastases in the era of SRS?

Halil Cumhur Yıldırım, Nuri Kaydıhan, Ecem Demir

|Dec 28, 2023
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?

Meltem Dağdelen, Tuba Kurt Çatal, Songül Çavdar Karaçam

|Oct 05, 2023
Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002).

Halil Cumhur Yıldırım, Fazilet Öner Dinçbaş, Volkan Demircan

|Jun 29, 2023
Correction: Adverse risk factors for salvage radiotherapy outcomes after radical prostatectomy in prostate cancer patients.

Halil Cumhur Yıldırım, Selvi Tabak Dinçer, Gökhan Yaprak

|May 18, 2023
Adverse risk factors for salvage radiotherapy outcomes after radical prostatectomy in prostate cancer patients.

Halil Cumhur Yıldırım, Selvi Tabak Dinçer, Gökhan Yaprak

Pageof 2